MARKET

QTTB

QTTB

Q32 BIO INC
NASDAQ
2.960
-0.220
-6.92%
After Hours: 2.980 +0.02 +0.68% 19:34 12/12 EST
OPEN
3.160
PREV CLOSE
3.180
HIGH
3.270
LOW
2.850
VOLUME
329.14K
TURNOVER
--
52 WEEK HIGH
27.61
52 WEEK LOW
1.345
MARKET CAP
36.42M
P/E (TTM)
-0.8582
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at QTTB last week (1201-1205)?
Weekly Report · 5d ago
Q32 Bio Inc. CFO and President Lee Kalowski Reports Sale of Common Shares
Reuters · 12/05 00:00
Q32 Bio CEO Jodie Pope Morrison Reports Sale of Common Shares
Reuters · 12/05 00:00
This Penny Biotech Stock Just Doubled on a Key Acquisition. Should You Buy Shares Here?
Barchart · 12/02 10:28
Q32 Bio Sells Complement Inhibitor ADX-097 To Akebia Therapeutics
NASDAQ · 12/02 08:36
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
TipRanks · 12/01 18:00
Crude Oil Gains Over 1%; ISM Manufacturing PMI Falls In November
Benzinga · 12/01 17:31
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 12/01 17:05
More
About QTTB
Q32 Bio Inc. is a clinical-stage biotechnology company whose science targets potent regulators of the adaptive immune system to re-balance immunity. The Company is focused on developing therapies for alopecia areata and other autoimmune and inflammatory diseases. The Company is advancing bempikibart (ADX-914), a fully human anti-IL-7Rα antibody that re-regulates adaptive immune function, for the treatment of alopecia areata in an ongoing Phase 2 program. The IL-7 and TSLP pathways have been genetically and biologically implicated in driving several T cell-mediated pathological processes in numerous autoimmune diseases. Additional discovery and earlier development efforts from its complement inhibitor platform include ADX-096, a C3d mAb - CR1 fusion protein which demonstrated preclinical data supportive of its use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition.

Webull offers Q32 Bio Inc stock information, including NASDAQ: QTTB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QTTB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading QTTB stock methods without spending real money on the virtual paper trading platform.